Chandler Robinson is the Chief Executive Officer of Monopar Therapeutics Inc., a clinical-stage biotechnology company, a role he has held since January 2015.
Chandler Robinson is the Chief Executive Officer of Monopar Therapeutics Inc., a clinical-stage biotechnology company, a role he has held since January 2015. Monopar focuses on late-stage treatments for Wilson disease and radiopharmaceutical programs for advanced cancers.
Full founder directory · Investor directory · Company funding database · Fundraising library